Abstract:Background:Endothelial-to-mesenchymal transition (EndMT) is the process by which endothelial cells lose their specific markers and acquire mesenchymal or myofibroblastic phenotypes. Studies have demonstrated the importance of endothelial-derived vascular smooth muscle cells (VSMCs) through EndMT in neointimal hyperplasia. Histone deacetylases (HDACs) are epigenetic modification enzymes involved in the epigenetic control of important cellular functions. Recent studies found that HDAC3, a class I HDAC, causes posttranslational modifications, including deacetylation and decrotonylation. However, the effect of HDAC3 on EndMT in neointimal hyperplasia via posttranslational modifications remains to be seen. Therefore, we investigated the effects of HDAC3 on EndMT in carotid artery-ligated mice and human umbilical vein endothelial cells (HUVECs) and the underlying posttranslational modifications.Methods:HUVECs were treated with transforming growth factor (TGF)-β1 or the inflammatory cytokine tumor necrosis factor (TNF)-α at different concentrations and durations. In HUVECs, HDAC3 expression, the expression of endothelial and mesenchymal markers, and posttranslational modifications were analyzed with Western blotting, quantitative real-time polymerase chain reaction (PCR), and immunofluorescence. C57BL/6 mice underwent left carotid artery ligation. Mice were treated with the HDAC3-selective inhibitor RGFP966 (10 mg/kg, i.p.) from 1 day before to 14 days after ligation. Then, the sections of the carotid arteries were examined histologically using hematoxylin and eosin (HE) and immunofluorescence staining. The carotid arteries from other mice were examined for the expression of EndMT markers and inflammatory cytokines. Furthermore, the acetylation and crotonylation of carotid arteries were immunostained in mice.Results:In HUVECs, TGF-β1 and TNF-α induced EndMT by decreasing CD31 expression and increasing α-smooth muscle actin expression. TGF-β1 and TNF-α also upregulated HDAC3 expression in HUVECs. The in vivo study in mice indicated that RGFP966 significantly alleviated neointimal hyperplasia of the carotid artery compared with vehicle treatment. Furthermore, RGFP966 suppressed EndMT and the inflammatory response in carotid artery-ligated mice. Further investigation revealed that HDAC3 regulated EndMT by posttranslational modifications of deacetylation and decrotonylation.Conclusions:These results suggest that HDAC3 regulates EndMT in neointimal hyperplasia through posttranslational modifications.

HDAC3 Inhibitor Suppresses Endothelial-to-mesenchymal Transition Via Modulating Inflammatory Response in Atherosclerosis

Regulation of Endothelial-to-mesenchymal Transition by Histone Deacetylase 3 Posttranslational Modifications in Neointimal Hyperplasia

Histone Deacetylase 3 is Critical in Endothelial Survival and Atherosclerosis Development in Response to Disturbed Flow

Histone Deacetylase 3: A Potential Therapeutic Target for Atherosclerosis

YIA1 Interaction Between HDAC3 and XBP1 is Critical in Maintainence of Endothelial Integrity

Histone Deacetylase 3 Unconventional Splicing Mediates Endothelial-to-mesenchymal Transition through Transforming Growth Factor β2

HDAC1 promotes artery injury through activation of VAV3 by binding to miR-182-5p in atherosclerotic mice model

BAS/BSCR26 Histone Deacetylase 3 Protects Endothelial Cells from Inflammation Via Regulation of Galectin 9 Expression

HDAC3 Downregulation Improves Cerebral Ischemic Injury via Regulation of the SDC1-Dependent JAK1/STAT3 Signaling Pathway Through miR-19a Upregulation

Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype

HDAC3 Inhibition in Diabetic Mice May Activate Nrf2 Preventing Diabetes-Induced Liver Damage and FGF21 Synthesis and Secretion Leading to Aortic Protection

Ablation of Interferon Regulatory Factor 3 Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice

HDAC3 Inhibition Prevents Oxygen Glucose Deprivation/reoxygenation‐induced Transendothelial Permeability by Elevating PPARγ Activity in Vitro

Mir‐34a Targets HDAC1‐Regulated H3K9 Acetylation on Lipid Accumulation Induced by Homocysteine in Foam Cells

High expression of liver histone deacetylase 3 contributes to high-fat-diet-induced metabolic syndrome by suppressing the PPAR-γ and LXR-α-pathways in E3 rats.

HDAC3 Mediates the Inflammatory Response and LPS Tolerance in Human Monocytes and Macrophages

Abstract 029: Interleukin-35 Suppresses Endothelial Activation by Inhibiting Mitochondrial Reactive Oxygen Species Mediated Site-specific Acetylation of Histone 3 Lysine 14

Abstract 23931: Selective Inhibition of Hdac3 Prevents Diabetic Cardiomyopathy in Ove26 Mice Via Mir-200a-mediated Nrf2 Activation

APOC3 induces endothelial dysfunction through TNF-α and JAM-1

Overexpression of CCN3 inhibits inflammation and progression of atherosclerosis in apolipoprotein E-deficient mice

HDAC4 Regulates Vascular Inflammation Via Activation of Autophagy.